Fig. 1From: A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion – an 18-month prospective cohort studyMedian number of injections in our ‘treat and extend’ cohort at 6, 12, and 18 months. Vertical lines represent interquartile rangeBack to article page